Objectives: To determine whether adjusting the denominator of the common hospital antibiotic use measurement unit (defined daily doses/100 bed-days) by including age-adjusted comorbidity score (100 bed-days/ age-adjusted comorbidity score) would result in more accurate and meaningful assessment of hospital antibiotic use.
Introduction
Evidence for a relationship between antibiotic use/misuse and the development of antibiotic-resistant bacteria, at both the individual and the population level, has been documented. 1 -4 This has subsequently increased morbidity, mortality and incurred additional hospital costs. 5, 6 Antibiotic resistance is a multifactorial problem that requires a multifactorial solution, of which optimizing antibiotic use has been considered a key component. 7 -9 The latter has been formalized through the establishment of hospital antibiotic stewardship programmes in a range of healthcare settings, which consist of a set of coordinated strategies to improve the use of antibiotic medications with the goal of enhancing patient health outcomes. 7 -10 The surveillance of hospital antibiotic use and resistance patterns is considered a key aspect of high-quality antibiotic stewardship implementation, evaluation and performance. To measure antibiotic use, the use of defined daily doses (DDDs) per 100 bed-days has been recommended by the WHO Collaborating Centre for Drug Statistics and Methodology. 10, 11 In healthcare settings, expressing antibiotic use as DDDs per 100 patient-days has been used as an indicator for antibiotic selection density (the proportion of patients receiving antibiotics in the hospital) and the selection pressure. However, this measure does not provide information on the number of patients actually exposed to antibiotics, possibly indicating the need for additional measurement units that will allow meaningful understanding of hospital antibiotic use. 12 Whereas there is a consensus regarding the role of antibiotic stewardship as a modality to improve patient care and healthcare outcomes, 7 -10 the most appropriate method for quantifying and reporting hospital antibiotic use is still debatable. 12 -14 Recently, an investigation with the objective of evaluating the effects of age-adjusted comorbidity and alcohol-based hand rub on monthly hospital antibiotic usage was carried out in the Antrim Area Hospital (Northern Ireland). The results showed that monthly antibiotic use was significantly related to the mean age-adjusted comorbidity index, a non-modifiable factor, indicating the possible utility of this variable in explaining hospital antibiotic use. 15 The objective of this study was to determine whether adjusting the denominator of the common hospital antibiotic use measurement unit (DDDs/100 bed-days) by including age-adjusted comorbidity score (100 bed-days/age-adjusted comorbidity score) would result in more accurate and meaningful assessment of hospital antibiotic use. The utility of this method for better informed hospital antibiotic stewardship and benchmarking was explored.
Methods

Setting and study design
The study was carried out in the Antrim Area Hospital [Northern Health and Social Care Trust (NHSCT), Northern Ireland], a 426 bed district general teaching hospital serving a population of 420000. The hospital provides all acute, general medical and surgical services, supports a range of outpatient facilities and acts as a centre for the coordination of health service provision throughout a defined geographical area in Northern Ireland. The study was ecological in design (i.e. an observational study in which data are measured at the group level) and consisted of two phases. Firstly, a model aimed at measuring the association between the monthly sum of age-adjusted comorbidity score (a proxy measure for patient case mix) and monthly antibiotic use was developed. A proxy measure is an indirect measure or indicator that represents a certain outcome in the absence of the availability of a direct or exact measure. In developing this model, other predictors {i.e. proxy measures for infection control practices [alcohol-based hand rub] and clinical pharmacy activity [clinical pharmacist full-time equivalents (FTEs)]} were included. The model was built for the period January 2008 to June 2012. Secondly, and for the purpose of conducting internal benchmarking, two antibiotic usage datasets (two study periods), i.e. antibiotic usage for 2004 -07 and 2008-11, were constructed. The determination of cut-off dates, at the end of period 1 and the start of period 2 in this second study phase, was based on the timing of an enhanced antibiotic stewardship programme, which was introduced in the study site hospital in January 2008. An overview of the study design and characteristics is provided in Figure S1 (available as Supplementary data at JAC Online).
Hospital data
Monthly antibiotic usage data for hospitalized adult patients were obtained from the pharmacy computer systems retrospectively and were converted into DDDs. Monthly data for alcohol-based hand rub (measured in L), clinical pharmacist FTEs and occupied patient bed-days were determined retrospectively from the hospital information system. Monthly hospital adult admissions, with their corresponding age-adjusted comorbidity data, were obtained from the hospital episode statistics. Age-adjusted comorbidity scores were calculated by combining age with the Charlson comorbidity index. 16 -18 The Charlson score is a weighted index that includes 19 diagnoses, and each diagnosis is weighted according to a 1 year relative risk of mortality. The weighted index reflects the severity of each comorbid disease. 16 -18 With age-adjusted comorbidity, an additional score is added for age (i.e. one point is added for each decade over the age of 40 years). Following this, the summation of the monthly patient age-adjusted Charlson comorbidity score was calculated for inclusion in the analysis. The collection of data included the intensive care unit (one eight-bed unit). The paediatric department was excluded from the study.
Enhanced antibiotic stewardship
Following a Clostridium difficile infection (CDI) outbreak, the Northern Health and Social Care Trust devised an antibiotic policy to minimize the use of high-risk antibiotics (second-generation cephalosporins, thirdgeneration cephalosporins, fluoroquinolones and clindamycin; January 2008), and classified other antibiotics as medium-risk (amoxicillin/clavulanic acid and macrolides) or low-risk antibiotics (all remaining antibiotics; September 2008). 19, 20 Clinical staff were encouraged to adhere to the hospital policy and their compliance with the hospital policy was observed and recorded using a standardized procedure form. 21 The use of antimicrobials not included in the policy was monitored through exemption forms, which required authorization by consultant physicians. The exemption forms were assessed by the antimicrobial management team (AMT) as appropriate or inappropriate with a written explanation. Results were directly shared with the prescribing physicians.
Antibiotic measure calculations
Antibiotic use was normalized per 100 bed-days and per 100 age-adjusted comorbidity score separately. A modified antibiotic usage measuring unit was devised to take into account both patient bed-days and patient 
Statistical analysis
Time-series analysis methods, including the use of linear transfer function techniques, were applied to study the relationship of age-adjusted comorbidity index, alcohol-based hand rub and clinical pharmacy activity to Aldeyab et al.
explain the use of antibiotics (see the Statistical analysis section in the Supplementary data available at JAC Online). 22 -28 The series were checked for stationarity (i.e. having a constant mean and variance) using the augmented Dickey-Fuller test for unit roots. 26 All variables were logarithmically transformed and first-order differencing was applied. The coefficient of determination (R 2 ), which corresponds to the percentage of the variance of the observed time-series explained by the model, was determined. Significance tests for parameter estimates were used to eliminate the unnecessary terms in the model. All analyses were performed using EViews 6 software (QMS, Irvine, CA, USA) and the SCA Statistical System software (River Forest, IL, USA). All results are reported based on the EViews software estimation summaries.
Results
Time-series analysis
Analysis of data showed that monthly antibiotic use had significant positive relationships with the sum of age-adjusted comorbidity score (concomitant effect; coefficient, 0.927; P¼ 0.0004; Table 1 ). This means that a level change in the sum of age-adjusted comorbidity score by 1% would cause a level change in antibiotic use by 0.927% (direct relationship). The results also showed that there was a negative relationship between antibiotic use and (i) alcohol-based hand rub use (2 months delay; coefficient, 20.085; P¼ 0.0370; Table 1 ) and (ii) clinical pharmacist FTEs (3 months delay; coefficient, 20.487303; P ¼ 0.0031; Table 1 ). This means that a level change in alcohol-based hand rub use and clinical pharmacist FTEs by 1% would cause a level change in antibiotic use by 0.085% and 0.487% (inverse relationship), respectively.
Based on examination of the residuals of the final model, adjustment was made for two outliers (i.e. February 2009 and March 2011) by inclusion of binary dummy variables (i.e. a value of 1 if an outlier is present; 0 otherwise.) in the model. For the final model, R 2 was 0.58, i.e. 58% of the variation in the monthly antibiotic use in the study site hospital was explained by the model. Graphs for antibiotic use versus sum of age-adjusted comorbidity score, alcohol-based hand rub and clinical pharmacist FTEs are shown in Figure 1 .
Modified measure and benchmarking
Age-adjusted comorbidity scores were calculated for 167576 admissions. Distributions of comorbidity and age-adjusted comorbidity score are shown in Table 2 . Data showed a strong association between the monthly sum of age-adjusted comorbidity score and the monthly number of admissions (Pearson's correlation, 0.92, P,0.0001). Over the two study periods (2004 -07 and 2008 -11), the average observed monthly antibiotic use was 8062.7 and 11407.6 DDDs, respectively, with an increasing trend in antibiotic use being observed (P,0.0001; Tables 3 and 4) . Similar increasing trends were observed for both study periods when antibiotic use was normalized per 100 bed-days (P,0.0001; Table 4 ). Characteristics and trends in monthly antibiotic use are shown in Tables 3 and 4 . The average monthly sums of age-adjusted comorbidity scores for both study periods were 4194.3 and 5061.5, respectively; an increasing trend was observed (P,0.0001; Table 4 ). When antibiotic use was normalized per age-adjusted comorbidity and per bed-days/age-adjusted comorbidity, a significant increasing trend was observed for the period 2004-07 (P,0.0001 and P,0.0027, respectively). However, antibiotic use during the period 2008-11 for both DDDs/age-adjusted comorbidity score and DDDs/100 bed-days/age-adjusted comorbidity score remained stable (P,0.1311 and P,0.6857, respectively; Table 4 ). Plots for monthly antibiotic use (DDDs) versus use of antibiotics normalized for different denominators (i.e. bed-days, age-adjusted comorbidity score and bed-days/age-adjusted comorbidity score) are presented in Figure 2 . Graphs for antibiotic use DDDs/100 bed-days versus (i) antibiotic use DDDs/age-adjusted comorbidity scores and (ii) DDDs/100 bed-days/age-adjusted comorbidity score are shown in Figure 3 .
The average observed monthly antibiotic use during the second study period was higher (115.8 DDDs/100 bed-days, 2008 -11) than during the first study period (88.7 DDDs/100 bed-days; Table 3 ). This has contributed to a comparative usage rate of 1.31, i.e. after considering patient density, antibiotic use during the second period of the study was 31% higher than that during the first study period (Table 5 ). Normalizing antibiotic use per age-adjusted comorbidity score resulted in a comparative usage rate of 1.06, i.e. after taking into account the effect of patient case mix, antibiotic use during the second period of the study was 6% higher than that during the first study period. Considering a denominator that took into account both patient density and patient case mix characteristics led to a comparative usage rate of 0.98 (Table 5) , i.e. the average antibiotic use was 2% lower in the second study period. Importantly, the latter comparative usage rate is independent of differences in patient density and case mix characteristics between the two studied populations. The exclusion of specific antibiotic agents showed similar patterns of decreasing overall antibiotic use when considering the studied adjustment units (Table 5) . 29, 30 with several studies suggesting excessive use, thus making it difficult to conduct proper benchmarking across hospitals. 3, 31, 32 High antibiotic use in a particular setting is often justified by clinicians as relating to differences in patient morbidities. 33 -35 The measurement of patient comorbidity may therefore play a major role in explaining variations in hospital antibiotic use and subsequently facilitating the conduct of more realistic benchmarking.
The results of the present research showed that monthly antibiotic use was significantly related to the age-adjusted comorbidity score. The importance of measuring comorbidity lies in its ability to predict morbidity, mortality, cost, hospitalization and the burden of the disease. 16 -18 As such, this factor can provide risk-adjustment criteria for patient case mix purposes and can have a vital role in explaining trends and variation in hospitals' antibiotic use. 15 Interestingly, changing age-adjusted comorbidity score had a much higher impact within the model when compared with the two other significant variables ( Table 1 ). The latter observation, together with the fact that the role of patients' age-adjusted comorbidity as a proxy measure for the disease burden has been proven, 16 -18 suggested the possible utility of this non-modifiable variable as an appropriate denominator for the calculation and presentation of hospital antibiotic use. The findings of the study also showed that an increase in the use of alcohol-based hand rub was associated with a decrease in antibiotic use. Antibiotics administered to patients in hospital are used to treat community-and healthcare-acquired infections.
The use of alcohol-based hand rub was shown to be an effective method to reduce the spread and acquisition of healthcareacquired infections in hospitals; the latter are associated with significant increases in length of hospital stay and antibiotic treatment. 24, 36, 37 It is interesting to note that variations in hospital pathogens' prevalence might be followed by similar variations in pathogens' prevalence in the surrounding community. MacKenzie et al. 38 showed that the monthly prevalence of methicillinresistant Staphylococcus aureus (MRSA) in the community was strongly related to the monthly MRSA prevalence observed 1 month previously in the hospital, suggesting that the reason for the increase in MRSA prevalence in the community was a hospital MRSA outbreak. Thus, increasing use of alcohol-based hand rub, which is a proxy measure for adequately practised infection control, might be leading to a subsequent reduction in hospital antibiotic use. However, further prospective research is needed to assess the impact of enhancing different infection control practices (e.g. alcohol-based hand rub, surveillance activity, education, etc.) on antibiotic use in healthcare settings.
In addition, the number of clinical pharmacist FTEs was used as a proxy measure for clinical pharmacy activity. The results showed that an increase in the clinical pharmacy services provided across the hospital was associated with a decrease in antibiotic use. This is in line with other local research that showed that medicine appropriateness is improved via improved medication management by the clinical pharmacy team. 39 In Antrim Area Hospital, a major CDI outbreak occurred in 2008. 19 The CDI outbreak was ended following the implementation of an action plan that involved improving communication, infection control practices, environmental hygiene and surveillance, and enhanced antibiotic stewardship. 19 The latter involved the implementation, led by the AMT, of prospective auditing of antimicrobial use with direct interaction and feedback to the prescriber, formulary restriction and a preauthorization strategy. 19, 21 With such high awareness of the problem of antibiotic use and resistance in this hospital, the statistically significant increasing usage trend and the observed 31% increase in average antibiotic use (DDDs/100 bed-days) during the implementation of enhanced antibiotic stewardship (second study period; Tables 4 and 5) contradicted the natural expected outcomes. Nevertheless, adjusting antibiotic usage DDDs per age-adjusted comorbidity score resulted in only a 6% antibiotic use increase during the enhanced antibiotic stewardship period, highlighting the value of considering patient A modified method for measuring antibiotic use case mix when expressing hospital antibiotic use. Such findings were consistent with the non-significant antibiotic use trend, which was observed during the second study period (DDDs/ age-adjusted comorbidity; Table 4 ). However, taking into account a more robust unit of measurement (i.e. DDDs/100 bed-days/ age-adjusted comorbidity score) has shown a reduction in the average antibiotic use by 2% (during the second study period). This reduction in antibiotic use, together with the significant reduction in high-risk antibiotics (described elsewhere), 19, 20 demonstrates the success of this antibiotic stewardship in the study site hospital and confirms its value in the management of hospital antibiotic use. The study has several strengths. Firstly, the employed statistical regression technique has taken cognizance of the problem of dependency existing between consecutive observations and for identifying lag effects between predictors and the outcome series, thus measuring significant relationships accurately. 40 Secondly, the study used robust risk-adjustment criteria for the patient case Aldeyab et al.
mix (i.e. the Charlson index), which is considered as the gold standard to assess comorbid risk in clinical research and uses readily available hospital databases. 16 -18 Thirdly, analysis showed a strong association between the monthly sum of age-adjusted comorbidity score and the number of monthly admissions. This is of importance since age-adjusted comorbidity score can reflect 12 Fourthly, antibiotic use and the age-adjusted comorbidity score were calculated for all hospitalized adult patients; thus, information and selection bias were unlikely. Finally, adjustment was made for the confounding effect of different healthcare systems and hospital policies since the study used an internal benchmarking approach in the same study site hospital.
However, the study has the following limitations. Firstly, although it is possible to argue that the increase in antibiotic use during the second study period was an apparent increase due to the increase in amoxicillin and amoxicillin/clavulanic acid, the exclusion of these agents showed similar patterns of decreasing overall antibiotic use when considering the presented adjustment measures (Table 5 ). This indicates that the increase in antibiotic use was genuine and possibly related to different reasons. Secondly, it is possible that other potential drivers for increased antibiotic use could be related to hospital infection rates and duration of treatment. Research from the study site Trust showed that the intervention introduced in 2008 (i.e. restricting high-risk antibiotics) had a positive impact on reducing the incidence rates of specific hospital pathogens (i.e. CDI pathogens, extended-spectrum b-lactamase-producing bacteria and MRSA). 19, 20, 41, 42 In addition, the quality of antibiotic prescribing and adherence to guidelines was continuously scrutinized and improved. 21, 43 For example, adherence to the Trust antibiotic policy was improved after 2008 21, 43 compared with prior periods. 44 Thirdly, it was not possible to determine accurate data for the entire study period with regard to other types of infection (e.g. surgical site infections, ventilator-associated pneumonia) to assess its relation with antibiotic use and age-adjusted comorbidity score; this requires further prospective research in different hospitals. However, the presence of multiple comorbidities is an indicator of patients in suboptimal health who may be unable to mount an effective immune response to bacterial challenge, and as such might facilitate patient colonization/infection with pathogens; the age-adjusted comorbidity score provides a convenient measure for the latter.
Fourthly, the Charlson index might be limited in its applicability to complex processes of care and functional outcomes since it does not incorporate physiological data to assess the severity of comorbid conditions and does not include functional impairment attributable to pre-existing comorbid conditions. 17 Finally, further research is needed to compare antibiotic use by different hospital departments, and to evaluate the proposed benchmarking approach using external groups and involving several hospitals across different countries with high and low volumes of antibiotic use.
In conclusion, the proposed modified antibiotic use unit of measurement provided an innovative approach to the measurement of actual trends in antibiotic use and the comparison of variations in antibiotic prescribing between hospitals, taking account of the effect of patient case mix. It facilitated the evaluation of antibiotic stewardship more accurately and can enable more informative benchmarking between hospitals. It is interesting to note that other identified predictors are considered modifiable factors, thus leaving room for quality improvement in antibiotic use. Age-adjusted comorbidity score calculations (utilizing the Charlson index) are relatively easy to apply, based on availability of clinical diagnosis. 17 In addition to expressing antibiotic use per 100 bed-days, hospitals should be encouraged to express their antibiotic use per 100 bed-days/age-adjusted comorbidity score in order to allow the calculation of a comparative usage rate, while taking into account the effect of patient case mix. Following the determination of the percentage difference in antibiotic use, based on the identified antibiotic comparative usage rate, antibiotic policy makers should investigate the reasons behind a high or low antibiotic usage rate, thus identifying targets for quality improvement in the former and presenting best antibiotic prescribing practice for adoption by others in the latter.
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